Mednet Logo
HomeQuestion

How would you approach antithrombotic therapy in patients with acute ischemic infarcts and a non-occlusive intracranial thrombus?

3
4 Answers
Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

I agree with the previous answer and can expand on a few key management nuances involving stroke size, symptom severity, and etiology. For stroke size, I typically initiate anticoagulation (heparin drip) if less than one-third of the affected territory is involved, extrapolating from tPA guidelines....

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · Vanderbilt University Medical Center

I am unaware of data on this question, but it makes sense that an intraluminal thrombus might cause further ischemia. I would favor a few days of IV heparin, followed by reimaging and switching to antiplatelet Rx if the thrombus has resolved.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · University of Virginia, School of Medicine

While there are no clinical trials that guide us to what the best approach is. I usually try to discern first if what we see is atherosclerotic stenosis or a non-occlusive thrombus. If someone had a prior CTA or MRA available then I would compare the vessels in terms of if there was prior stenosis o...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · University of Minnesota

Post the stroke mentioned, I would use 2 platelet inhibitors for 4 weeks, then usually ASA alone.

Register or Sign In to see full answer

How would you approach antithrombotic therapy in patients with acute ischemic infarcts and a non-occlusive intracranial thrombus? | Mednet